Rtw Investments, LP sold $132 of OBIO
owner at Orchestra BioMed Holdings, Inc.. 32 shares at an average of $4.13, traded Apr 27, 2026, filed Apr 29, 2026.
Score components
- +12Role10% owner
- 0Trade size$132 at market
- 0Share of holdings soldSold 0.0% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-26-000427, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | XIn-the-money exercise Common Stockindirect: See footnote | +1,250,032 | $0.00 | $125 | 9,556,095 | Apr 29, 2026 |
| Apr 27, 2026 | SOpen-market sale Common Stockindirect: See footnote | -32 | $4.13 | $132 | 9,556,063 | Apr 29, 2026 |
| Apr 27, 2026 | XIn-the-money exercise Pre-Funded Warrants (Right to Buy)derivativeindirect: See footnote | -1,250,032 | $2.75 | $3.4M | 2,386,331 | Apr 29, 2026 |
Related signals
Other insiders at Orchestra BioMed Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $95k 15,000 shares | -1% | |
| 34Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $48k 10,000 shares | +1% | |
| 3Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $74k 15,000 shares | -1% | |
| 31Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $11k 2,000 shares | - | |
| 2Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $61k 15,000 shares | -1% | |
| 3Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $64k 15,000 shares | -1% | |
| 32Weak | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $19k 5,000 shares | +0% | |
| 2Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $58k 15,000 shares | -1% | |
| 34Weak | Orchestra BioMed Holdings, Inc. | Jason Aryeh director | $2,494 665 shares | +1% | |
| 47Moderate | Orchestra BioMed Holdings, Inc. | Jason Aryeh director | $35k 8,971 shares | +8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.